Clinical trials

Responsive Stimulation for Adolescents with Epilepsy (RESPONSE) Study

To determine if the RNS system is safe and effective as an adjunctive therapy for individuals ages 12 through 17 years, who are diagnosed with medically refractory partial onset epilepsy...

Cohen Children's Medical Center/Division of Pediatric Neurology | 2001 Marcus Avenue | Lake Success | NY 11042

Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (with or without aura) in Children and Adolescents = 6 to <18 Years of Age

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

Multiple locations

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age with Episodic Migraine – the REBUILD-1 Study

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine.

Cohen Children's Medical Center/Division of Pediatric Neurology | 2001 Marcus Avenue | Lake Success | NY 11042

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age...

Cohen Children's Medical Center/Division of Pediatric Neurology | 2001 Marcus Avenue | Lake Success | NY 11042

Clinical trials : pediatric-neurology

Employees